Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05221905Phase 1Completed
Phase 1, randomised, double-blind trial (3 arms), sponsored by University of Virginia. Primary endpoint: Flow-Mediated Dilation. Started Nov 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05221905.